Iranian Red Crescent Medical Journal

Published by: Kowsar

Autologous stem cell transplantation with moderate dose of Idarubicin and Busulphan as conditioning regimen in acute myelogenous leukemia

MA Mashhadi 1 , * , M Ramzi 2 and K Alimoghaddam 3
Authors Information
1 Assistant Professor of Hematology and Oncology Unit, Department of Internal Medicine, Zahedan University of Medical Sciences, dralimashhadi@yahoo.com, Sistan Baloochestan, Iran
2 Hematology and Oncology Research Center, Department of Internal Medicine, Shiraz University of Medical Sciences, Fars, Iran
3 Hematology and Oncology Unit, Department of Internal Medicine, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Red Crescent Medical Journal: 10 (3); 205-210
  • Article Type: Research Article
  • Received: February 14, 2008
  • Accepted: June 22, 2008

To Cite: Mashhadi M, Ramzi M, Alimoghaddam K. Autologous stem cell transplantation with moderate dose of Idarubicin and Busulphan as conditioning regimen in acute myelogenous leukemia, Iran Red Crescent Med J. Online ahead of Print ; 10(3):205-210.

Abstract
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments